Synthesis 2009(5): 759-766  
DOI: 10.1055/s-0028-1083373
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Practical Syntheses of Sphingosine-1-Phosphate and Analogues

Virginie Blota, Ulrich Jacquemarda, Hans-Ulrich Reissig*a, Burkhard Kleuserb
a Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
Fax: +49(30)83855367; e-Mail: hans.reissig@chemie.fu-berlin.de ;
b Institut für Pharmazie, Freie Universität Berlin, Königin-Luise Str. 2-4, 14195 Berlin, Germany
Further Information

Publication History

Received 18 July 2008
Publication Date:
11 February 2009 (online)

Abstract

Sphingosine-1-phosphate (S1P, 1) is a bioactive sphingolipid metabolite involved in a variety of critical cellular processes including proliferation, survival, and migration. For this reason the stereoselective syntheses of S1P and analogues are of great interest. Based on l-serine as source of chirality we achieved practical routes to prepare S1P (1) and the aryl group containing analogues 3 and 4 in fair amounts. The crucial stages of the syntheses are: introduction of the required side chain by addition of appropriate organometallics to Garner’s aldehyde and conversion of the primary alcohols into the corresponding phosphates.

    References

  • 1 Ishii I. Fukushima N. Ye X. Chun J. Annu. Rev. Biochem.  2004,  73:  321 
  • 2 Lim HS. Park JJ. Ko K. Lee MH. Chung SK. Bioorg. Med. Chem. Lett.  2004,  14:  2499 
  • 3 Takabe K. Paugh SW. Milstien S. Spiegel S. Pharmacol. Rev.  2008,  60:  181 
  • 4 Tarnowski A. Retz O. Bär T. Schmidt RR. Eur. J. Org. Chem.  2005,  1129 
  • For recent reviews on chemistry and biology of sphingosine derivatives, see:
  • 5a Liao J. Tao J. Lin G. Liu D. Tetrahedron  2005,  61:  4715 
  • 5b Koskinen PM. Koskinen AMP. Synthesis  1998,  1075 
  • For publications on the synthesis of d-(2S,3R)-sphingosine and references cited, see:
  • 6a Merino P. Jimenez P. Tejero T. J. Org. Chem.  2006,  71:  4685 
  • 6b Kim S. Lee S. Ko H. Kim D. J. Org. Chem.  2006,  71:  8661 
  • 6c Yamamoto T. Hasegawa H. Hakogi T. Katsumura S. Org. Lett.  2006,  8:  5569 
  • 6d Yang H. Liebeskind LS. Org. Lett.  2007,  9:  2993 
  • For selected publications on recent synthesis of sphingosine analogues, see:
  • 7a Grijalvo S. Llebaria A. Delgado A. Synth. Commun.  2007,  37:  2737 
  • 7b Kim S. Lee YM. Kang HR. Cho J. Lee T. Kim D. Org. Lett.  2007,  9:  2127 ; and references cited therein
  • For other syntheses of sphingosine using l-serine, see:
  • 8a Radunz HE. Devant RM. Eiermann V. Liebigs Ann. Chem.  1988,  1103 
  • 8b Herold P. Helv. Chim. Acta  1988,  71:  354 
  • 8c Garner P. Park JM. Malecki E. J. Org. Chem.  1988,  53:  4395 
  • 8d Nimkar S. Menaldino D. Merrill AH. Liotta D. Tetrahedron Lett.  1988,  29:  3037 
  • 8e Soai K. Takahashi K. J. Chem. Soc., Perkin Trans. 1  1994,   1257 
  • 8f Azuma H. Tamagaki S. Ogino K. J. Org. Chem.  2000,  65:  3538 
  • 8g Murakami T. Furusawa K. Tetrahedron  2002,  58:  9257 
  • 8h Chun J. Li G. Byun H.-S. Bittman R. Tetrahedron Lett.  2002,  43:  375 
  • 8i Suzuki H. Mori M. Shibakami M. Synlett  2003,  2163 
  • 8j Sawatzki P. Kolter T. Eur. J. Org. Chem.  2004,  3693 
  • 8k Murakami T. Furusawa K. Tamai T. Yoshikai K. Nishikawa M. Bioorg. Chem. Med. Lett.  2005,  15:  1115 
  • 8l Okamoto N. Kanie O. Huang Y.-Y. Fujii R. Watanabe H. Shimamura M. Chem. Biol.  2005,  12:  677 
  • 8m

    Reference 6c.

  • 8n Ohshita K. Ishiyama H. Takahashi Y. Ito J. Mikami Y. Kobayashi J. Bioorg. Med. Chem.  2007,  15:  4910 
  • 9 For reviews concerning Garner’s aldehyde, see: Liang X. Andersch J. Bols M. J. Chem. Soc., Perkin Trans. 1  2001,  2136 
  • 10a Dondoni A. Perrone D. Synthesis  1997,  527 
  • 10b Williams L. Zhang Z. Shao F. Carroll PJ. Joullié MM. Tetrahedron  1996,  52:  11673 
  • 10c Yonezawa Y. Shimizu K. Yoon K.-S. Shin C.-G. Synthesis  2000,  634 
  • 11 Chun J. He LL. Byun HS. Bittman R. J. Org. Chem.  2000,  65:  7634 
  • 12 Review on ionic hydrogenations: Kursanov DN. Parnes ZN. Loim MM. Synthesis  1974,  633 
  • Selected applications of ionic hydrogenations:
  • 13a Kraus GA. Frazier KA. Roth BD. Taschner MJ. Neuenschwander K. J. Org. Chem.  1981,  46:  2417 
  • 13b Kraus GA. Molina MT. Walling JA. J. Org. Chem.  1987,  52:  1273 
  • 13c Badirad SA. Wang Y. Kishi Y. J. Org. Chem.  1987,  52:  1370 
  • 13d Brückner C. Holzinger H. Reissig H.-U. J. Org. Chem.  1988,  53:  2450 
  • 13e Arndt S. Emde U. Bäurle S. Friedrich T. Grubert L. Koert U. Chem. Eur. J.  2001,  7:  993 
  • 14 Szulc ZM. Hannun YA. Bielawska A. Tetrahedron Lett.  2000,  41:  7821 
  • 15 Oza VB. Corcoran RC. J. Org. Chem.  1995,  60:  3680 
  • 16a Lim HS. Oh YS. Suh PG. Chung SK. Bioorg. Med. Chem. Lett.  2003,  13:  237 
  • 16b Kratzer B. Schmidt RR. Tetrahedron Lett.  1993,  34:  1761 
17

The scaling-up, essentially following our protocol, provided S1P 1 in quantities of more than 100 g.